Primary perivascular epithelioid cell tumors (PEComas) of the pancreas are extremely rare. We herein report our experience with a patient who had a primary PEComa of the pancreas that was diagnosed by the preoperative histopathological examination of a biopsy specimen obtained by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA). The patient was a 43-year-old woman whose chief complaint was abdominal pain. Imaging studies revealed a pancreatic tumor. Gastrointestinal stromal tumor (GIST), solid pseudopapillary tumor and neuroendocrine tumor were considered in the differential diagnosis. A histopathological examination of a specimen of the tumor obtained using EUS-FNA showed spindle-shaped tumor cells with enlarged nuclei and eosinophilic cytoplasm. The tumor cells proliferated in a sheet-like fashion and stained positive for the melanoma-associated antigen HMB-45. A PEComa was thus diagnosed. If an adequate tumor specimen can be obtained using EUS-FNA, immunostaining may facilitate the diagnosis of extremely rare diseases and therefore assist in deciding the treatment policy.
Introduction
Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms that are characterized by the presence of perivascular epithelioid cells (PECs). The tumor cells are epithelioid or spindle-shaped and tend to be distributed around blood vessels (1) (2) (3) . The cells uniquely show immunoactivity for melanocytic markers such as HMB-45 or myogenic markers such as α-smooth muscle actin (α-SMA) (2) . Angiomyolipomas (AML) arising in the kidney or liver, clear cell "sugar" tumors (CCSTs) arising in the lung and lymphangiomyomatosis (LAM) are included in the family of tumors arising from PECs, and are referred to as 
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puted tomography (CT) revealed a mass, measuring 10 cm in diameter, near the pancreas. The patient presented at our hospital for further evaluation 3 days after the onset of abdominal pain. There was no family history that was relevant to the current disorder. The patient was not a smoker and did not drink alcohol. Upon physical examination, the abdominal pain had improved, but mild tenderness was present from the upper to the left side of the abdomen. A fist-sized mass was palpated in the same region. The results of the blood tests are shown in Table 1 . As for tumor makers, the CA125 level was slightly elevated, but negative results were obtained for carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), alpha-fetoprotein (AFP), pancreatic cancer-associated antigen-2 (DUPAN-2), SPan-1, progastrinreleasing peptide (proGRP) and neuron-specific enolase (NSE). A CT scan showed a relatively well-demarcated mass (10 cm, maximum diameter) in the body and tail of the pancreas. Plain CT revealed an intermingling of high signal intensity inside the tumor, suggesting the presence of bleeding. The tumor showed no contrast enhancement in the A. B. A. B.
early phase. In the late phase, the lesion was slightly attenuated as compared with the surrounding parenchyma of the pancreas. A tear was seen at the cranial margin of the tumor, and a soft-tissue density contiguous with this region was found in the surrounding area, suggesting the presence of a hematoma associated with tumor rupture (Fig. 1 ). EUS showed a hypoechoic mass, 10 cm in diameter, in contact with the stomach and pancreas. The inside of the mass was heterogeneous and included a cystic component (Fig. 2) .
Abdominal angiography of the celiac artery suggested that the dorsal pancreatic artery, the branches of the left gastric artery, the pancreatic branches of the splenic artery and the branches arising from around the origin of the middle hepatic artery were the feeding vessels of the mass. Selective angiography of the dorsal pancreatic artery showed a densely stained mass and a drainage vein. The mass was also darkly stained on angiography of the pancreatic branches of the splenic artery (Fig. 3) . The imaging findings suggested a gastrointestinal stromal tumor (GIST), a solid pseudopapillary tumor or a neuroendocrine tumor of the pancreas. However, the imaging characteristics of the mass were not consistent with any of these tumors. EUS-FNA (a total of 4 punctures with a 22-gauge needle through the stomach) was therefore performed in order to establish the preoperative diagnosis. A histopathological examination of the specimens (Fig. 4) obtained by EUS-FNA (Fig. 2) showed spindle-shaped tumor cells with enlarged nuclei and eosinophilic cytoplasm that were proliferating in a sheet-like fashion. A PEComa was diagnosed on the basis of the results of immunostaining (Table 2 ). Subsequently, the patient underwent resection of the body and tail of the pancreas, as well as splenectomy and partial gastrectomy. A histopathalogical examination of the tumor (Fig. 5) showed similar features as the specimens obtained by EUS-FNA, and the tumor was confirmed to be contiguous to the pancreas. These findings were consistent with a primary PEComa of the pancreas. The postoperative histopathological diagnosis was a primary PEComa of the pancreas, consistent with the preoperative diagnosis. As of 7 months after surgery, there has been no evidence of recurrence or metastasis. However, the recurrence of malignant PEComa following surgery has been reported in the literature (10); therefore, a close follow-up is mandatory.
Discussion
Primary PEComas of the pancreas are extremely rare. Between 1996 and 2012, only 11 cases, including ours, were reported in the PubMed / MEDLINE database ( Table 3) (2, 4-12). The patient group included 9 women and 2 men with a mean age of 49 years (range, 31 to 74). The presenting symptoms included abdominal pain in 7 of the patients, diarrhea in 1 of the patients, a bulge in the right upper quadrant in 1 of the patients and cold-like symptoms (fever, coughing and fatigue) in 1 of the patients. One of the patients was asymptomatic, and PEComa was only serendipitously detected using ultrasonography. The tumors were located in the pancreatic head in 5 of the patients, in the pancreatic body in 5 of the patients and in the pancreatic uncinate process in 1 of the patients. The mean tumor diameter was 33 mm (range, 15 to 100 mm). Tumor rupture was found only in our patient.
Our patient had a large tumor, which had already ruptured at the time of detection. For massive tumors, it is often difficult to determine the organ of origin. In our patient, EUS showed that the tumor was in contact with both the pancreas and the stomach, therefore making it difficult to identify the primary organ. GIST was included in the differential diagnosis on the basis of the results of the imaging studies. GISTs of the stomach generally arise from the fourth layer of the gastric wall (muscularis). Submucosal tumors derived from the fourth layer include GISTs, leiomyomas and neurinomas (13) . GISTs occasionally have a region of central necrosis. In patients with GISTs of the stomach, curative surgery may be precluded by tumor rupture. We were therefore planning to perform surgery after downstaging the tumor using imatinib therapy. However, a PEComa was diagnosed based on the histopathological examination of the specimens obtained by EUS-FNA, and an earlier surgery was instead selected. Our patient is the 3rd reported case of primary PEComa of the pancreas to be preoperatively diagnosed using EUS-FNA. If adequate biopsy specimens can be obtained using EUS-FNA, immunostaining can contribute to the final diagnosis as well as assist in the determination of the treatment policy for this very rare disease.
The natural history of PEComas, including the extremely rare primary PEComa of the pancreas, is unpredictable and has yet to be fully elucidated. PEComas are known to be potentially malignant, but a classification of the malignant potential has yet to be established. Based on a study of 26 patients with PEComa of either the soft tissue or the female urogenital tract, Folpe et al. reported the following "worrisome features": a tumor diameter of >5 cm, infiltrative growth, a high nuclear grade and cellularity, a mitotic rate of >1/50 high-power fields, necrosis and vascular invasion. They proposed that tumors with 2 or more of these features should be defined as malignant (14) . Further studies are therefore necessary in order to establish a definitive system for classifying the malignant potential of PEComas. The extreme rarity of primary PEComas arising in the pancreas might contribute to the difficulty of preoperatively diagnosing this tumor. However, PEComas should be included in the differential diagnosis of pancreatic tumors. If atypical pancreatic tumors are encountered, then EUS-FNA should be performed. Immunostaining can provide information on important pathological features, thus facilitating an accurate preoperative diagnosis.
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